The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

Painful periods are often considered normal, but severe menstrual pain that interferes with daily activities, requires ...

"Somewhere between 35-80% of people with PMOS experience insulin resistance, making weight management important." ...

We’ve recommended mirvetuximab soravtansine (also called Elahere and developed by AbbVie) for treating folate receptor-alpha-positive platinum-resistant epithelial ovarian, fallopian tube or primary ...

Lemme, the award-winning wellness brand co-founded by Kourtney Kardashian Barker, introduces Lemme Balance Capsules, an ...

For women with advanced high-grade serous ovarian cancer (OC), short-term fasting (STF) may enhance the efficacy of ...

So much for great egg-spectations. Most women are born with an ovary on each side of their uterus. These almond-shaped glands produce and release eggs for fertilization and secrete the hormones ...

A £600 million tranche of government funding for a key part of the UK's life sciences strategy – expanding the country's ...

"If you are diagnosed with Polyendocrine Metabolic Ovarian Syndrome, it doesn't mean that you are destined to have poor ...

Patients who fasted during chemotherapy for ovarian cancer had significantly longer progression-free survival (PFS) compared ...

Digital health tools, including wearables, provide critical data on menstrual health, enhancing understanding of hormonal ...

About one in eight women – or around 170 million people – globally are diagnosed with PCOS, and despite how common the ...